Biotechnology News

Wed, 2013-10-02 12:00

ST. LOUIS--(BUSINESS WIRE)--Monsanto Company (NYSE: MON) today announced fiscal year 2013 results near the high end of its guidance range, the third straight year of greater than 20 percent ongoing earnings growth. Executives noted the company is...

Wed, 2013-10-02 12:00

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced that Brian E. Ward, Ph.D., President and Chief Executive Officer,...

Wed, 2013-10-02 12:00

PARSIPPANY, N.J.--(BUSINESS WIRE)--Precision Spine Announces Expanded FDA 510(k) Clearance For the Reform Pedicle Screw System

Wed, 2013-10-02 12:00

FORT WAYNE, Ind.--(BUSINESS WIRE)--Matrix-Bio, a leader in metabolite profiling-based cancer diagnostics, has named life sciences veteran Deb Neff to its Board. Neff has built companies and guided cancer diagnostic tests to market.

Wed, 2013-10-02 12:00

GERMANTOWN, Wis. & WILMINGTON, N.C.--(BUSINESS WIRE)--Cambridge Major Laboratories, Inc. and AAIPharma Services Corp. have announced their intent to merge to form a premium global supplier of integrated CMC services.

Wed, 2013-10-02 12:00

VALENCIA, Spain & AARHUS, Denmark--(BUSINESS WIRE)--CLC bio and BioBam announce an integrated workflow for researchers working with non-model organisms without reference sequences.

Wed, 2013-10-02 12:00

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq:ACOR) will present new research at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) on AMPYRA® (dalfampridine) Extended...

Wed, 2013-10-02 12:00

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides CEO Dr. Euegene Seymour will present Corporate Overview at the LD Micro Invitational to be held in Los Angeles today.

Wed, 2013-10-02 12:00

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Partner Technology Powers Better Models, Better Research

Wed, 2013-10-02 07:00

NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals Announces Plans to Initiate a Phase 2 Study of SP-333 for Opioid-Induced Constipation

Wed, 2013-10-02 07:00

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist will focus on its expanded pipeline of antibiotics, represented through presentations during IDWeek 2013. Presentations will also highlight CUBICIN® (daptomycin for injection).

Wed, 2013-10-02 07:00

CHELMSFORD, Mass.--(BUSINESS WIRE)--Spectro Inc., a Chelmsford, Mass.-based developer and manufacturer of analytical tools and software for the industrial performance fluids market, announced it has purchased Wilks Enterprises Inc.

Wed, 2013-10-02 07:00

DUBLIN--(BUSINESS WIRE)--Opsona Therapeutics Limited (Opsona), the innate immune drug development company, today announced that it has raised an additional €3 million (US $4 million) in a second closing of its previously announced Series C equity...

Wed, 2013-10-02 07:00

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN - ADR: IPSEY) (Paris:IPN) today announced its project1 of new organization and new composition of the Executive Committee (ExCom) to accelerate strategy implementation. The purpose of...

Tue, 2013-10-01 21:00

CHICAGO--(BUSINESS WIRE)--Marshall, Gerstein & Borun, an intellectual property law firm, was recognized as Patent Strategy and Management: Team of the Year by LMG Life Sciences during the LMG Life Sciences Awards ceremony.

Tue, 2013-10-01 21:00

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical launches Entuit enteral feeding products.

Tue, 2013-10-01 21:00

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX), an international manufacturer and marketer of pharmaceutical products, will release its Fiscal 2014 Second Quarter financial results before the U.S. stock market opens on Tuesday,...

Tue, 2013-10-01 21:00

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that its New Drug Application (NDA) for tavaborole, its drug candidate for the topical treatment of onychomycosis, has been accepted by the U.S. Food and...

Tue, 2013-10-01 21:00

BELMONT, Calif.--(BUSINESS WIRE)--LakePharma Inc., the leading CRO specializing in antibody and protein engineering, is hosting an Antibody Engineering Symposium in South San Francisco on Friday, October 4, 2013.

Tue, 2013-10-01 21:00

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) and NanoString Technologies, Inc. (NASDAQ:NSTG) have agreed to settle lawsuits filed by Fluidigm against NanoString.

Tue, 2013-10-01 21:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq:BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today announced that the company has been...

Tue, 2013-10-01 21:00

PARSIPPANY, N.J.--(BUSINESS WIRE)--Pacira Pharmaceuticals, Inc. Announces Partnership to Support Uptake of EXPAREL® Among the Orthopedic Marketplace

Tue, 2013-10-01 16:01

BEND, Ore.--(BUSINESS WIRE)--Modern QbD-based Formulation Platform for Insoluble APIs

Tue, 2013-10-01 16:01

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Vikon® Surgical, a developer of emerging surgical technologies, has acquired the ONE Technology platform and its first product, the ONE HEADLIT® surgical headlight, from Alpha Med-Surge, Inc.

Tue, 2013-10-01 16:01

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck will present interim data from its Phase IB expansion study evaluating MK-3475 in patients with refractory NSCLC at the 15th World Conference on Lung Cancer on Oct. 29 in Sydney, Australia.

Tue, 2013-10-01 16:01

YOKNEAM, Israel--(BUSINESS WIRE)--EndoCross reports early success with first-in-human study of its ENABLER-C Catheter System

Tue, 2013-10-01 16:01

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the treatment and management of chronic pain, peripheral neuropathies, and related neurological disorders, today announced that it has...

Tue, 2013-10-01 16:01

HUMMELSTOWN, Pa.--(BUSINESS WIRE)--Apogee will present interim data from the first-in-human trial of ABC294640, its drug to treat advanced solid tumors, at the Molecular Targets & Cancer Therapeutics meeting in Boston on Oct. 22, 2013.

Tue, 2013-10-01 16:01

ROCKVILLE, Md.--(BUSINESS WIRE)--ABL to Develop and Manufacture PATH's Shigella Vaccine for Phase I Clinical Trial

Tue, 2013-10-01 16:01

PRINCETON, N.J.--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: Bristol-Myers Squibb to Present Range of New Hepatitis C Data at the 2013 American...

Tue, 2013-10-01 16:01

BOSTON--(BUSINESS WIRE)--On September 30, 2013, H&Q Life Sciences Investors paid a quarterly stock distribution of $0.35 per share. It is currently estimated that $0.34 of this distribution is derived from long-term and $0.01 from short-term...

Tue, 2013-10-01 16:01

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, October 29, 2013. The purpose of the call is to provide an...

Tue, 2013-10-01 16:01

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb to Announce Results for Third Quarter 2013 on October 23

Tue, 2013-10-01 16:01

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc., (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that Peter Nielsen, President and Chief Executive...

Tue, 2013-10-01 16:01

BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. announces today the results of its Phase 2 sustained release dexamethasone study for the treatment of post-operative inflammation and pain.

Tue, 2013-10-01 16:01

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that six...

Tue, 2013-10-01 16:01

HOBOKEN, N.J.--(BUSINESS WIRE)--Octapharma USA will present seven clinical posters at the National Hemophilia Foundation’s Annual Meeting, emphasizing the company’s commitment to support the bleeding disorders community.

Tue, 2013-10-01 11:01

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck will present data from studies evaluating the company’s investigational oral chronic hepatitis C virus (HCV) treatments MK-5172 and MK-8742 at the 64th AASLD, Nov. 1-5, 2013.

Tue, 2013-10-01 11:01

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that it has launched its activities in the US...

Tue, 2013-10-01 11:01

BERKELEY, Calif.--(BUSINESS WIRE)--ExThera Medical Corporation and blood-banking leader BioBridge Global will collaborate in a research program to apply ExThera’s Seraph® Microbind® technology

Tue, 2013-10-01 11:01

LAKE OSWEGO, Ore.--(BUSINESS WIRE)--BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced it has received approval from the Food and Drug Administration (FDA) for its Ilesto family of implantable cardioverter-...

Tue, 2013-10-01 11:01

BOSTON & GENEVA--(BUSINESS WIRE)--PHT Clinical Science & Consulting sees strong growth & expands service offerings as more pharmaceutical sponsors and CROs leverage PHT’s clinical science advice and best practices from 650+ trials.

Tue, 2013-10-01 11:01

EMERYVILLE, Calif.--(BUSINESS WIRE)--Seed Matters™, an initiative of Clif Bar Family Foundation, today announced four new fellowships totaling $500,000 awarded to Ph.D. students studying organic plant breeding.

Tue, 2013-10-01 11:01

MENLO PARK, Calif. & ALAMEDA, Calif.--(BUSINESS WIRE)--Asterias Biotherapeutics, Inc. and BioTime, Inc. (NYSE MKT: BTX) jointly announced today the closing of the transactions under the Asset Contribution Agreement (the “Agreement”) with...

Tue, 2013-10-01 11:01

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announces the launch of the generic equivalent to Zemplar® (paricalcitol) tablets in the United States as of September 30, 2013. Teva was first to file, making the...

Tue, 2013-10-01 11:01

SUZHOU, China--(BUSINESS WIRE)--The Suzhou Industrial Park (SIP) is pioneering a path that China as a whole hopes to emulate by shifting its economy away from low-end manufacturing and up the value chain.

Tue, 2013-10-01 11:01

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Welch Allyn today announced the availability of its new connectivity-ready CP 150™ electrocardiograph device in Canada.

Tue, 2013-10-01 11:01

EDMONTON, Alberta--(BUSINESS WIRE)--The Board of Directors for BioAlberta, the Life Sciences Industry Association for the Province of Alberta, is pleased to name Ms. Amanda Stadel as the incoming President of the association, effective...